ARTICLE | Clinical News
Ampion: Phase III started
April 8, 2013 7:00 AM UTC
Ampio began a 2-part, double-blind, placebo-controlled Phase III trial of Ampion. The first run-in portion will compare 4 and 10 mL injections of Ampion in 320 patients and will determine the optimal ...